GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Total Operating Expense

Endo (NDOI) Total Operating Expense : $349.2 Mil (TTM As of Mar. 2025)


View and export this data going back to 2024. Start your Free Trial

What is Endo Total Operating Expense?

Endo's Total Operating Expense for the three months ended in Mar. 2025 was $180.7 Mil. Endo's Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 was $349.2 Mil.

Endo Total Operating Expense Historical Data

The historical data trend for Endo's Total Operating Expense can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Endo Total Operating Expense Chart

Endo Annual Data
Trend Dec22 Dec23 Dec24
Total Operating Expense
905.20 683.19 -

Endo Quarterly Data
Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25
Total Operating Expense Get a 7-Day Free Trial 155.97 - 168.51 - 180.68

Endo Total Operating Expense Calculation

Total Operating Expense is the primary recurring expense associated with central operations that are incurred in order to generate sales.


Total Operating Expense for the trailing twelve months (TTM) ended in Mar. 2025 adds up the quarterly data reported by the company within the most recent 12 months, which was $349.2 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Endo Total Operating Expense Related Terms

Thank you for viewing the detailed overview of Endo's Total Operating Expense provided by GuruFocus.com. Please click on the following links to see related term pages.

Endo Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Endo Inc (OTCPK:NDOI) » Definitions » Total Operating Expense
Comparable Companies
SUPN ANIP BCRX DVAX KNSA HROW AMPH PCRX PAHC COLL ZTS XTER:MRK NSE:SUNPHARMA TSE:4502 LSE:HLN XSWX:GALD XSWX:SDZ HKSE:03692 NSE:DIVISLAB XTAE:TEVA
Traded in Other Exchanges
N/A
Address
9 Great Valley Parkway, Malvern, PA, USA, 19355
Website
https://www.endo.com
Endo Inc is a diversified pharmaceutical company. It has four reportable business segments: (1) Branded Pharmaceuticals, (2) Sterile Injectables, (3) Generic Pharmaceuticals and (4) International Pharmaceuticals. Branded Pharmaceuticals segment includes a variety of branded products in the therapeutic areas of urology, orthopedics, etc. Sterile Injectables segment consists of branded sterile injectable products such as ADRENALIN, VASOSTRICT and APLISOL, among others. Generic Pharmaceuticals segment includes a product portfolio including patches, solid oral extended-release products, etc. Key revenue is generated from International Pharmaceuticals segment includes a variety of specialty pharmaceutical products, including OTC products, sold outside the U.S.